Over The Counter Drug
Over The Counter Drug
Over The Counter Drug
AVIGNA
4/15/2012
AVIGNA
4/15/2012
HISTORY
ROSE Case in 1704. Set benchmark in the history of medicines. Pharmacist can prescribe and dispense medicines breaking the monopoly of college of physicians. Available till 1860. After few set back continued till 1960.
AVIGNA
4/15/2012
1848190219061911 19381962-
Drug importation act Biologics control act(Virus serum toxin act) Wileys act(Pure food and drug act) Shirley's amendment Sulphonelamyl tragedy Thalidomide tragedy
AVIGNA
4/15/2012
OUTCOMES
AVIGNA
4/15/2012
Over-the-counter (OTC) drugs are drugs and combinations that do not require a registered medical practioner prescription. Many OTC drug ingredients had been previously approved prescription drugs now deemed safe enough for use without a medical practioner's supervision.
AVIGNA
4/15/2012
ME TOO DRUG Drugs which are very similar to known or existing drug with only minor differences.
BEHIND THE COUNTER DRUG Drugs which doesnt require Doctors prescription but requires discussion with Pharmacist prior to purchase
AVIGNA 7 4/15/2012
Consumed
AVIGNA 9 4/15/2012
45%
52%
POSSIBLE BENEFITS
Increased access Decreased frequency of visits to physicians, leading to lower healthcare costs Improved education of consumers Increased autonomy of patients Decreased cost to third party players
AVIGNA
11
4/15/2012
POSSIBLE RISKS
Inaccurate diagnosis Drug resistance Increased costs to patients Failure to follow label instructions (Adverse effects, Drug interactions) Perceived loss of control by physicians
AVIGNA
12
4/15/2012
THALIDOMIDE TRAGEDY
NEVER GIVE UP !!
AVIGNA
13
4/15/2012
INDIAN CONTEXT
Control,Regulation,Sales
AVIGNA
14
4/15/2012
INDIAN OTC
The Phrase OTC have no legal recognition. The Drugs which are not included in the PRESCRIPTION only considered as OTC. No official list of OTC.
AVIGNA
15
4/15/2012
INDIAN OTC
PRESCRIPTION Only Drugs are included in Schedule H and Schedule X of DCR.
Schedule G doesnt require Prescription but requires Mandatory labeling. Schedule K can be sold under Non-Drug License Store.
AVIGNA
16
4/15/2012
INDIAN OTC
Ayurvedic medicines(natural and herbal ingredients) regulated by DCA and DCR. Manufacturing license is giving by State authority and doesnt require Drug license to sell. It includes Plant based active ingredient( ex. Vicks vaporub, Amrutanjan pain balm, Iodex pain balm, Moov, etc.)
AVIGNA
17
4/15/2012
INDIAN OTC
AVIGNA
Broadly Indian OTC Categories include, Traditional medicines Cough and cold Vitamins and minerals Analgesics Skin problem Others(Antacid,Constipation,Diarrhea,Allergy)
18 4/15/2012
27.60%
2.60%
11.40% 11.60%
19.80%
AVIGNA
19
4/15/2012
GI ailments like acidity, constipation, diarrhea, nausea Skin ailments like acne, rashes, cuts and burns Nutritional supplements
AVIGNA 21
AVIGNA
22
4/15/2012
PATIENT INFORMATION
Patient information Rule 96 of DCR mandates the minimum information which needs to be put on the label Proper(generic)and trade(brand) name Active ingredients and net contents Name and address of the manufacture/ license number/batch number/expiry date Maximum retail price(Inclusive of all taxes)
AVIGNA 23 4/15/2012
TRADE NAMES
Trade names Regulated by Trade and merchandise marks act(TMMA) Provides registration for the period of seven years at a time and renewable after each period Foreign trade mark can be used without any restriction with their local subsidiaries or joint ventures
AVIGNA
24
4/15/2012
ADVERTISEMENTS
Advertising of OTC Drugs and magic remedies(objectionable advertisements) act and rules mention certain ailments for which no advertisements is permitted False or Misleading advertisements No specific laws governing the advertisements
AVIGNA 25 4/15/2012
AVIGNA
26
4/15/2012
Strengthen the Patent office infrastructure Focus to R&D strategies to increase anti cancer and anti HIV drug Rationalize excise duty to promote more access for poor Set up Drugs price monitoring awareness and accessibility fund Create a Pharma advisory Forum
AVIGNA 27 4/15/2012
AVIGNA
28
4/15/2012
The Indian pharmaceutical industry is a success story providing employment for millions and ensuring that essential drugs at affordable prices are available to the vast population of this sub-continent. Richard Gerster
AVIGNA
29
4/15/2012
AVIGNA
30
4/15/2012
INDIAN MARKET
Indian pharmaceutical market as on october 2010 is valued around Rs 50,000 crore
AVIGNA
32
4/15/2012
Growth drivers Income demographics Aging population and new social disease
AVIGNA
33
4/15/2012
Consumer Research
Research Methodology Research Type No. of Respondents Age Group Gender - Male - Female Non-Probability (Convenient Sampling) 99 16-44 73 26
AVIGNA
34
4/15/2012
23.76%
Doctor
AVIGNA
Pharmacist
Self medication
35
Do nothing
4/15/2012
1. How do you feel if your Doctor is enquiring about the medicine you have taken before consulting him/her?
20%
AVIGNA
36
4/15/2012
1. How do you feel if your Doctor is enquiring about the medicine you have taken before consulting him/her?
5% 30%
35%
30%
AVIGNA
37
4/15/2012
1. How do you feel if your Doctor is enquiring about the medicine you have taken before consulting him/her?
2% 33% 38%
27%
AVIGNA
38
4/15/2012
1. How do you feel if your Doctor is enquiring about the medicine you have taken before consulting him/her?
9% 22%
20%
49%
AVIGNA
39
4/15/2012
2. Q1. The chemist is a good source for advice/information for minor medical problems
Stongly Agree Agree Disagree Strongly Disagree No Response
5% 1%
11%
21%
64%
AVIGNA
40
4/15/2012
2. Q2. It is important to have medicines /treatments that you can buy to relieve minor medical problem
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
1% 7%
14%
22%
56%
AVIGNA
41
4/15/2012
2. Q3. Reading the pack is one of the way I decide which medicines/treatments to go for.
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
3% 12%
15%
18%
52%
AVIGNA
42
4/15/2012
4% 1%
10%
48%
37%
AVIGNA
43
4/15/2012
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
4% 13%
13%
28%
42%
AVIGNA
44
4/15/2012
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
AVIGNA
45
4/15/2012
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
4%
17%
5% 34%
40%
AVIGNA
46
4/15/2012
28%
12% 25%
6% 29%
AVIGNA
47
4/15/2012
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
23% 5%
11% 31%
30%
AVIGNA
48
4/15/2012
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
1% 0%
14% 42%
43%
AVIGNA
49
4/15/2012
2. Q11. People are less likely to bother their doctor with minor
problem nowadays
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
2% 15%
15%
16%
52%
AVIGNA
50
4/15/2012
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
8%
12%
13% 19%
48%
AVIGNA
51
4/15/2012
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
3%
19%
6%
18%
54%
AVIGNA
52
4/15/2012
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
4%
15%
9%
21% 51%
AVIGNA
53
4/15/2012
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
AVIGNA
54
4/15/2012
from doctor/nurse
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
1% 6% 10% 36%
47%
AVIGNA
55
4/15/2012
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
1%
0% 12%
34%
53%
AVIGNA
56
4/15/2012
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
1% 13%
15%
15%
56%
AVIGNA
57
4/15/2012
effective
Stongly Agree
Agree
Disagree
Strongly Disagree
No Response
3%
18%
6% 29%
44%
AVIGNA
58
4/15/2012
INFERENCE
Read the label Treat only the symptoms you have Know what to avoid while taking OTCs ASK before you buy Use as directed on the label Be careful if you take > 1 OTC Dont mix Rx and OTCs including herbals Give your doctor a list of ALL medicines For kids, use pediatric formulas Throw medicines away if they are expired
59 4/15/2012
AVIGNA
Reference
Organization of Pharmaceutical Producers of India OTC article by vijay bhangle OTC marketing article by Ajith paninchukanath CIA World fact book www.google.com www.youtube.com
AVIGNA
60
4/15/2012